Akira Yuasa

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Antimicrobial Resistance

Health Insurance

Atopic Dermatitis

Staphylococcus Aureus

Top Venues

Infectious diseases and therapy

The Journal of dermatology

Future oncology (London, England)

PharmacoEconomics - open

This page only lists publications with an associated author ORCID identifier.

Publications

Akio Tanaka, Akira Yuasa, Kazumasa Kamei, Mitsuhiro Nagano, Toshiaki Murofushi, Annika Bjerke, Kouki Nakamura, Shunya Ikeda
Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan. The Journal of dermatology 51 (6) (2024)
Tetsuya Matsumoto, Akira Yuasa, Hiroyuki Matsuda, Dilinuer Ainiwaer, Naohiro Yonemoto
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis. Infectious diseases and therapy 13 (5) (2024)
Ana Paula Arantes Bueno, Otávio Clark, Matthew Turnure, Eloisa S Moreira, Akira Yuasa, Shigeru Sugiyama, Melissa Kirker, Si Li, Ningqi Hou, Jane Chang, Mairead Kearney, Gena Kanas
Treatment patterns in metastatic bladder cancer in Japan: results of the CancerMPact ® survey 2020. Future oncology (London, England) 20 (10) (2024)
Akio Tanaka, Akira Yuasa, Kazumasa Kamei, Mitsuhiro Nagano, Toshiaki Murofushi, Annika Bjerke, Kouki Nakamura, Shunya Ikeda
Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan. The Journal of dermatology (2024)
Tetsuya Matsumoto, Akira Yuasa, Hiroyuki Matsuda, Dilinuer Ainiwaer, Naohiro Yonemoto
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis. Infectious diseases and therapy 13 (5) (2024)
Akio Tanaka, Akira Yuasa, Kazumasa Kamei, Mitsuhiro Nagano, Toshiaki Murofushi, Annika Bjerke, Kouki Nakamura, Shunya Ikeda
Cost-effectiveness analysis of abrocitinib compared with standard of care in adult moderate-to-severe atopic dermatitis in Japan. The Journal of dermatology 51 (6) (2024)
Ana Paula Arantes Bueno, Otávio Clark, Matthew Turnure, Eloisa S Moreira, Akira Yuasa, Shigeru Sugiyama, Melissa Kirker, Si Li, Ningqi Hou, Jane Chang, Mairead Kearney, Gena Kanas
Treatment patterns in metastatic bladder cancer in Japan: results of the CancerMPact ® survey 2020. Future oncology (London, England) (2024)
Ana Paula Arantes Bueno, Otávio Clark, Matthew Turnure, Eloisa S Moreira, Akira Yuasa, Shigeru Sugiyama, Melissa Kirker, Si Li, Ningqi Hou, Jane Chang, Mairead Kearney, Gena Kanas
Treatment patterns in metastatic bladder cancer in Japan: results of the CancerMPact ® survey 2020. Future oncology (London, England) 20 (10) (2024)
Tetsuya Matsumoto, Akira Yuasa, Hiroyuki Matsuda, Dilinuer Ainiwaer, Naohiro Yonemoto
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis. Infectious diseases and therapy 13 (5) (2024)
Tetsuya Matsumoto, Akira Yuasa, Hiroyuki Matsuda, Dilinuer Ainiwaer, Naohiro Yonemoto
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis. Infectious diseases and therapy (2024)
Motoyuki Sugai, Akira Yuasa, Ryan L Miller, Vasileios Vasilopoulos, Hitomi Kurosu, Amer Taie, Jason P Gordon, Tetsuya Matsumoto
Correction to: An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan. Infectious diseases and therapy (2023)
Motoyuki Sugai, Akira Yuasa, Ryan L Miller, Vasileios Vasilopoulos, Hitomi Kurosu, Amer Taie, Jason P Gordon, Tetsuya Matsumoto
An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan. Infectious diseases and therapy (2023)
Taisuke Ito, Kazumasa Kamei, Akira Yuasa, Fumihiro Matsumoto, Yayoi Hoshi, Masafumi Okada, Shinichi Noto
Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons. The Journal of dermatology 49 (6) (2022)
Tetsuya Matsumoto, Akira Yuasa, Ryan Miller, Clive Pritchard, Takahisa Ohashi, Amer Taie, Jason Gordon
Estimating the Economic and Clinical Value of Introducing Ceftazidime/Avibactam into Antimicrobial Practice in Japan: A Dynamic Modelling Study. PharmacoEconomics - open (2022)
Akira Yuasa, Naohiro Yonemoto, Kazumasa Kamei, Toshiaki Murofushi, Michael LoPresti, Ankush Taneja, Jake Horgan, Shunya Ikeda
Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders. Advances in therapy 39 (12) (2022)
Atsuyuki Igarashi, Akira Yuasa, Naohiro Yonemoto, Kazumasa Kamei, Michael LoPresti, Toshiaki Murofushi, Shunya Ikeda
A Systematic Literature Review of Economic Evaluations and Cost Studies of the Treatment of Psoriasis, Atopic Dermatitis, and Chronic Urticaria. Dermatology and therapy 12 (8) (2022)
Akira Yuasa, Naohiro Yonemoto, Michael LoPresti, Shunya Ikeda
Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review. Expert review of pharmacoeconomics & outcomes research 21 (2) (2021)
Tomoyuki Takura, Akira Yuasa, Naohiro Yonemoto, Sven Demiya, Hiroyuki Matsuda, Nozomi Ebata, Koichi Fujii, Muneaki Ishijima
Cost-Effectiveness Analysis of the Treatment Strategies with or without Opioid Medications in Surgery-Eligible Patients with Osteoarthritis in Japan. PharmacoEconomics - open (2021)
Akira Yuasa, Tatsunori Murata, Keiji Imai, Yuji Yamamoto, Yoko Fujimoto
Treatment procedures and associated medical costs of methicillin-resistant Staphylococcus aureus infection in Japan: A retrospective analysis using a database of Japanese employment-based health insurance. SAGE open medicine 7 (2019)